BRIEF-Summit Completes Dosing Of Ezutromid In Phaseout Dmd Clinical Trial

* SUMMIT COMPLETES DOSING OF EZUTROMID IN PHASEOUT DMD CLINICAL TRIAL
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.